Erratum for Kim S, et al. “Comparison of Early Strut Coverage Between Zotarolimus – and Everolimus -Eluting Stents Using Optical Coherence Tomography.” Am J Cardiol 2013;111:1–5

Dec 5, 2016 by in CARDIOLOGY Comments Off on Erratum for Kim S, et al. “Comparison of Early Strut Coverage Between Zotarolimus – and Everolimus -Eluting Stents Using Optical Coherence Tomography.” Am J Cardiol 2013;111:1–5

This paper has an error in Figure 2 on page 4. The corrected Figure 2 can be found below: The authors apologize for this error.

read more

Mitral Valve Geometry and Hemodynamics After Surgical Mitral Valve Annuloplasty and Implications for Percutaneous Treatment of Patients With Recurrent Mitral Regurgitation

Dec 5, 2016 by in CARDIOLOGY Comments Off on Mitral Valve Geometry and Hemodynamics After Surgical Mitral Valve Annuloplasty and Implications for Percutaneous Treatment of Patients With Recurrent Mitral Regurgitation

The feasibility of transcatheter mitral valve therapy (edge-to-edge or valve-in-ring technique) in patients with significant mitral regurgitation (MR) recurrence after surgical restrictive mitral valve annuloplasty remains unknown. The aim of…

read more

Relation Between Six-Minute Walk Test Performance and Outcomes After Transcatheter Aortic Valve Implantation (from the PARTNER Trial)

Dec 5, 2016 by in CARDIOLOGY Comments Off on Relation Between Six-Minute Walk Test Performance and Outcomes After Transcatheter Aortic Valve Implantation (from the PARTNER Trial)

Functional capacity as assessed by 6-minute walk test distance (6MWTD) has been shown to predict outcomes in selected cohorts with cardiovascular disease. To evaluate the association between 6MWTD and outcomes…

read more

Effectiveness of Spironolactone Plus Ambrisentan for Treatment of Pulmonary Arterial Hypertension (from the [ARIES] Study 1 and 2 Trials)

Dec 5, 2016 by in CARDIOLOGY Comments Off on Effectiveness of Spironolactone Plus Ambrisentan for Treatment of Pulmonary Arterial Hypertension (from the [ARIES] Study 1 and 2 Trials)

In translational models of pulmonary arterial hypertension (PAH), spironolactone improves cardiopulmonary hemodynamics by attenuating the adverse effects of hyperaldosteronism on endothelin type-B receptor function in pulmonary endothelial cells. This observation…

read more

Transfemoral Aortic Valve Implantation in Patients With an Annulus Dimension Suitable for Either the Edwards Valve or the CoreValve

Dec 5, 2016 by in CARDIOLOGY Comments Off on Transfemoral Aortic Valve Implantation in Patients With an Annulus Dimension Suitable for Either the Edwards Valve or the CoreValve

The aim of this study was to compare the outcomes of transcatheter aortic valve implantation using the Edwards SAPIEN valve and the Medtronic CoreValve in patients with annulus of intermediate…

read more

Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli

Dec 5, 2016 by in CARDIOLOGY Comments Off on Angina Pectoris or Myocardial Infarctions, Pulmonary Arteriovenous Malformations, Hereditary Hemorrhagic Telangiectasia, and Paradoxical Emboli

Hereditary hemorrhagic telangiectasia is an autosomal dominant disorder characterized by vascular malformations, and many clinical complications are related to pulmonary arteriovenous malformations (PAVMs) because they provide direct right-to-left shunts. Paradoxical…

read more

Trends in the Prevalence of Hospitalization Attributable to Hypertensive Diseases Among United States Adults Aged 35 and Older From 1980 to 2007

Dec 5, 2016 by in CARDIOLOGY Comments Off on Trends in the Prevalence of Hospitalization Attributable to Hypertensive Diseases Among United States Adults Aged 35 and Older From 1980 to 2007

We aimed to examine the trend in the prevalence of hospitalization attributable to hypertensive disease and its subtypes among United States adults aged ≥35 years from 1980 to 2007. Data…

read more
Get Clinical Tree app for offline access